Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.

Saved in:
Bibliographic Details
Title: Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.
Authors: Hernandez JJ; Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada., Pryszlak M; Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; The Hospital for Sick Children, Toronto, ON, Canada., Smith L; Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; The Hospital for Sick Children, Toronto, ON, Canada., Yanchus C; Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada., Kurji N; Cyclica Inc., Toronto, ON, Canada., Shahani VM; Cyclica Inc., Toronto, ON, Canada., Molinski SV; Cyclica Inc., Toronto, ON, Canada.
Source: Frontiers in oncology [Front Oncol] 2017 Nov 14; Vol. 7, pp. 273. Date of Electronic Publication: 2017 Nov 14 (Print Publication: 2017).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2017.00273